Alexander Snyder. 2021. “For Profit or For Health? It Is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies”. Pittsburgh Journal of Technology Law &Amp; Policy 21 (2). https://doi.org/10.5195/tlp.2021.251.